CH563405A5
(es)
|
1971-09-10 |
1975-06-30 |
Duschinsky Robert Dr Schweiz I |
|
IL51342A
(en)
|
1977-01-27 |
1980-11-30 |
Abic Ltd |
Ethoxyquin derivatives,their preparation and pharmaceutical and veterinary compositions comprising them
|
US4230698A
(en)
|
1978-05-12 |
1980-10-28 |
Research Corporation |
2-Substituted arabinofuranosyl nucleosides and nucleotides
|
US4211773A
(en)
|
1978-10-02 |
1980-07-08 |
Sloan Kettering Institute For Cancer Research |
5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
|
AU5118979A
(en)
|
1978-10-16 |
1980-04-24 |
Takeda Chemical Industries Ltd. |
2,6-diaminoebularines
|
US4652554A
(en)
|
1982-02-22 |
1987-03-24 |
St. Jude Children's Research Hospital |
Nitro-substituted 1-β-D-arabinofuranosylcytosines
|
JPS60228497A
(ja)
|
1984-04-27 |
1985-11-13 |
Sumitomo Chem Co Ltd |
新規なアデニル酸誘導体
|
US4713383A
(en)
|
1984-10-01 |
1987-12-15 |
Ciba-Geigy Corporation |
Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
|
US4626526A
(en)
|
1984-10-26 |
1986-12-02 |
Warner-Lambert Company |
(S)-N6 -2-hydroxypropyladenosines
|
US4855304A
(en)
|
1985-01-10 |
1989-08-08 |
Repligen Corporation |
Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals
|
JPS61219478A
(ja)
|
1985-03-26 |
1986-09-29 |
Potsupuribetsuto Fastener Kk |
溶接検知方法及び装置
|
PL144471B1
(en)
|
1985-04-22 |
1988-05-31 |
Polska Akad Nauk Centrum |
Method of obtaining novel 3',5'-cyclic adensine dithiophosphate
|
US4762823A
(en)
|
1985-10-16 |
1988-08-09 |
Sloan-Kettering Institute For Cancer Research |
Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil
|
US4797495A
(en)
|
1985-11-22 |
1989-01-10 |
Burroughs Wellcome Co. |
Benzo[c]carbazole propanediol compound and salts thereof
|
ES2005552A6
(es)
|
1986-04-14 |
1989-03-16 |
Shell Int Research |
Composicion herbicida de eter hetero ciclico halogenado, procedimiento para preparar este ester y metodo de reprimir plantas indeseables.
|
WO1988003147A1
(en)
|
1986-10-31 |
1988-05-05 |
Warner-Lambert Company |
Selected n6-substituted adenosines having selective a2 binding activity
|
SU1417408A1
(ru)
|
1986-12-02 |
1995-09-10 |
Г.П. Акулов |
Способ получения меченного тритием дезоксиаденозина
|
JPH0699467B2
(ja)
|
1987-03-04 |
1994-12-07 |
ヤマサ醤油株式会社 |
2▲’▼−デオキシ−2▲’▼(s)−アルキルピリミジンヌクレオシド誘導体
|
ATE113059T1
(de)
|
1987-06-24 |
1994-11-15 |
Florey Howard Inst |
Nukleosid-derivate.
|
DE3730542A1
(de)
|
1987-09-11 |
1989-04-06 |
Hoechst Ag |
Arzneimittel mit einem gehalt an bestimmten 6-mercaptopurin-derivaten, verwendung dieser 6-mercaptopurin-derivate, verfahren zur herstellung der arzneimittel sowie einige neue 6-mercaptopurin-derivate und verfahren zu deren herstellung
|
US4880784A
(en)
|
1987-12-21 |
1989-11-14 |
Brigham Young University |
Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
|
HU204843B
(en)
|
1988-09-27 |
1992-02-28 |
Merrell Dow Pharma |
Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
|
CA2002648C
(en)
|
1988-11-15 |
2000-02-29 |
James R. Mccarthy |
2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
|
MX9203459A
(es)
|
1988-11-15 |
1992-08-01 |
Merrell Pharma Inc |
Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
|
US5616702A
(en)
|
1988-11-15 |
1997-04-01 |
Merrell Pharmaceuticals Inc. |
2-'-ethenylidene cytidine, uridine and guanosine derivatives
|
NZ231444A
(en)
|
1988-11-21 |
1992-09-25 |
Syntex Inc |
2'-deoxy-4'-azido-substituted nucleosides and medicaments
|
SE462497B
(sv)
|
1988-11-30 |
1990-07-02 |
Clas Fredrik Runesson Kaelland |
Saett foer att aktivitetsbestaemma polymeraser
|
FR2642074B1
(fr)
|
1989-01-20 |
1994-04-29 |
Oris Ind |
Derives de molecules polyhydroxylees permettant l'introduction d'au moins une ramification dans un oligonucleotide
|
US5296348A
(en)
|
1989-05-16 |
1994-03-22 |
The Wistar Institute Of Anatomy And Biology |
Methods for screening monoclonal antibodies for therapeutic use
|
DE3916871A1
(de)
|
1989-05-24 |
1990-11-29 |
Boehringer Mannheim Gmbh |
Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
|
DE3924424A1
(de)
|
1989-07-24 |
1991-01-31 |
Boehringer Mannheim Gmbh |
Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
|
JPH0699711B2
(ja)
|
1989-07-25 |
1994-12-07 |
花王株式会社 |
液体洗浄剤組成物
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
DK0497875T3
(da)
|
1989-10-24 |
2000-07-03 |
Gilead Sciences Inc |
2'-modificerede oligonukleotider
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
US5514786A
(en)
|
1990-01-11 |
1996-05-07 |
Isis Pharmaceuticals, Inc. |
Compositions for inhibiting RNA activity
|
US5457191A
(en)
|
1990-01-11 |
1995-10-10 |
Isis Pharmaceuticals, Inc. |
3-deazapurines
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
JP2580091B2
(ja)
|
1990-01-11 |
1997-02-12 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
Rna活性および遺伝子発現を検出および変調するための組成物および方法
|
US5852188A
(en)
|
1990-01-11 |
1998-12-22 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having chiral phosphorus linkages
|
CA2037767A1
(en)
|
1990-03-23 |
1991-09-24 |
Mark D. Wittman |
Conversion of amines to hydroxylamines
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5478813A
(en)
|
1990-05-11 |
1995-12-26 |
Banyu Pharmaceutical Co., Ltd. |
Antitumor substance BE-13793C derivatives
|
AU7623991A
(en)
|
1990-05-17 |
1991-11-21 |
Syntex (U.S.A.) Inc. |
Antiviral agents
|
GB9012899D0
(en)
|
1990-06-09 |
1990-08-01 |
Wellcome Found |
Anti-hbv pyrimidine nucleoside
|
JP2559917B2
(ja)
|
1990-06-15 |
1996-12-04 |
三共株式会社 |
ピリミジンヌクレオシド誘導体
|
DE4019892A1
(de)
|
1990-06-22 |
1992-01-02 |
Boehringer Ingelheim Kg |
Neue xanthinderivate
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5378825A
(en)
|
1990-07-27 |
1995-01-03 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
US5777100A
(en)
|
1990-08-10 |
1998-07-07 |
Gensia Inc. |
AICA riboside analogs
|
IL99125A0
(en)
|
1990-08-10 |
1992-07-15 |
Gensia Pharma |
Derivatives of imidazole analog of aica riboside and their use
|
US6262241B1
(en)
|
1990-08-13 |
2001-07-17 |
Isis Pharmaceuticals, Inc. |
Compound for detecting and modulating RNA activity and gene expression
|
US5420115A
(en)
*
|
1990-09-10 |
1995-05-30 |
Burroughs Wellcome Co. |
Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
WO1992012718A1
(en)
|
1991-01-23 |
1992-08-06 |
Gensia, Inc. |
Adenosine kinase inhibitors
|
US5171849A
(en)
|
1991-04-19 |
1992-12-15 |
The Ohio State University Research Foundation |
2' and 3' Carboranyl uridines and their diethyl ether adducts
|
US5446031A
(en)
|
1991-04-24 |
1995-08-29 |
Yamasa Shuyu Kabushiki Kaisha |
1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
|
GB9111580D0
(en)
|
1991-05-30 |
1991-07-24 |
Wellcome Found |
Nucleoside derivative
|
US5192764A
(en)
|
1991-05-30 |
1993-03-09 |
Research Foundation Of State Of N.Y. |
Pyrazinone n-oxide nucleosides and analogs thereof
|
US5508407A
(en)
|
1991-07-10 |
1996-04-16 |
Eli Lilly And Company |
Retroviral protease inhibitors
|
JPH0551395A
(ja)
|
1991-08-21 |
1993-03-02 |
Teijin Ltd |
ペンタフルオロプロピオニル化(デオキシ)ウリジンおよびそれを用いる(デオキシ)ウリジンの測定方法
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
DE4131579A1
(de)
|
1991-09-23 |
1993-03-25 |
Boehringer Mannheim Gmbh |
Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel
|
CA2079413C
(en)
|
1991-09-30 |
2003-09-09 |
Masakatsu Kaneko |
Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
|
US6335434B1
(en)
|
1998-06-16 |
2002-01-01 |
Isis Pharmaceuticals, Inc., |
Nucleosidic and non-nucleosidic folate conjugates
|
IT1249732B
(it)
|
1991-11-26 |
1995-03-09 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso.
|
ATE226093T1
(de)
|
1991-11-26 |
2002-11-15 |
Isis Pharmaceuticals Inc |
Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen
|
US6235887B1
(en)
|
1991-11-26 |
2001-05-22 |
Isis Pharmaceuticals, Inc. |
Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
|
FR2684997A1
(fr)
|
1991-12-12 |
1993-06-18 |
Centre Nat Rech Scient |
Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.
|
FR2688003B1
(fr)
|
1992-02-28 |
1995-06-30 |
Univ Limoges |
Derives de nucleosides, leur preparation et leurs applications biologiques.
|
US5543507A
(en)
|
1992-03-05 |
1996-08-06 |
Isis Pharmaceuticals, Inc. |
Covalently cross-linked oligonucleotides
|
ES2123642T3
(es)
|
1992-04-10 |
1999-01-16 |
Merrell Pharma Inc |
Metodo para el tratamiento del cancer por terapia conjunta con derivados de 2'-halometilideno y un agente antineoplasico especifico de fase s o fase m.
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
US5808139A
(en)
|
1992-04-21 |
1998-09-15 |
Ligand Pharmaceuticals Incorporated |
Non-steroid progesterone receptor agonist and antagonist and compounds and methods
|
EP0640092B1
(en)
|
1992-05-12 |
1996-12-11 |
Merrell Pharmaceuticals Inc. |
A process for the preparation of ribonucleotide reductase inhibitors
|
US5625056A
(en)
|
1992-05-26 |
1997-04-29 |
Biolog Life Science Institute |
Derivatives of cyclic guanosine-3',5'-monophosphorothioate
|
DE4217679C2
(de)
|
1992-05-26 |
1998-02-19 |
Genieser Hans Gottfried Dr |
Cyclische Guanosin-3',5'-phosphorothioat-Derivate
|
DE69333344T2
(de)
|
1992-07-23 |
2004-10-07 |
Isis Pharmaceutical Inc |
Neue 2'-0-Alkyl-Nukleoside und Phosphoramidite, Verfahren zu deren Herstellung und deren Verwendung
|
AU6449294A
(en)
|
1993-03-31 |
1994-10-24 |
Sterling Winthrop Inc. |
Novel 5'-substituted nucleosides and oligomers produced therefrom
|
JP4086314B2
(ja)
|
1993-09-17 |
2008-05-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヌクレオチドアナログ
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US6004939A
(en)
|
1995-07-06 |
1999-12-21 |
Ctrc Research Foundation Board Of Regents |
Methods for modulation and inhibition of telomerase
|
CA2246162C
(en)
|
1996-01-23 |
2000-04-04 |
Icn Pharmaceuticals, Inc. |
Modulation of th1/th2 cytokine expression by ribavirin.rtm. and ribavirin.rtm. analogs in activated t-lymphocytes
|
JPH09328497A
(ja)
*
|
1996-04-12 |
1997-12-22 |
Yamasa Shoyu Co Ltd |
4’−フルオロメチルヌクレオシド
|
JP2001524936A
(ja)
|
1996-10-16 |
2001-12-04 |
アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド |
プリンl―ヌクレオシド類およびその用途
|
CZ120699A3
(cs)
|
1996-10-16 |
1999-09-15 |
Icn Pharmaceuticals, Inc. |
Monocyklická L-nukleosidová analoga a jejich využití
|
US20030064945A1
(en)
|
1997-01-31 |
2003-04-03 |
Saghir Akhtar |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
EP2253639A1
(en)
|
1997-09-12 |
2010-11-24 |
Exiqon A/S |
Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
|
US20030203862A1
(en)
|
1998-03-26 |
2003-10-30 |
Miraglia Loren J. |
Antisense modulation of MDM2 expression
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
AU4322799A
(en)
|
1998-05-28 |
1999-12-13 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
WO2000056748A1
(en)
*
|
1999-03-18 |
2000-09-28 |
Exiqon A/S |
Xylo-lna analogues
|
EP1178999B1
(en)
|
1999-05-04 |
2007-03-14 |
Santaris Pharma A/S |
L-ribo-lna analogues
|
ATE250622T1
(de)
|
1999-05-12 |
2003-10-15 |
Yamasa Corp |
4'-c-ethynyl-pyrimidine nukleoside
|
JP4076114B2
(ja)
|
1999-05-12 |
2008-04-16 |
ヤマサ醤油株式会社 |
4’−c−エチニルプリンヌクレオシド化合物
|
CA2381297A1
(en)
|
1999-08-27 |
2001-04-19 |
Esmir Gunic |
Pyrrolo¬2,3-d|pyrimidine nucleoside analogs
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
IL133680A0
(en)
|
1999-09-10 |
2001-04-30 |
Can Fite Technologies Ltd |
Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
|
JP2003516962A
(ja)
|
1999-12-16 |
2003-05-20 |
アルコン,インコーポレイテッド |
視神経損傷および網膜損傷の処置のためのアデノシンキナーゼのインヒビター
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
JP2002322192A
(ja)
*
|
2000-08-10 |
2002-11-08 |
Sankyo Co Ltd |
2’−o,4’−c−架橋ヌクレオシドトリリン酸体
|
JP2004313002A
(ja)
|
2000-10-12 |
2004-11-11 |
Mitsui Chemicals Inc |
ヌクレオシドの製造方法
|
WO2002031176A1
(fr)
|
2000-10-12 |
2002-04-18 |
Mitsui Chemicals, Inc. |
Procédé permettant la production de nucléosides
|
CN1646141B
(zh)
*
|
2000-10-18 |
2014-06-25 |
吉利德制药有限责任公司 |
用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
|
IL156704A0
(en)
|
2001-01-16 |
2004-01-04 |
Can Fite Biopharma Ltd |
Use of an adenosine a3 receptor agonist for inhibition of viral replication
|
EP1355916B1
(en)
|
2001-01-22 |
2007-01-10 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
JP2002302498A
(ja)
|
2001-04-03 |
2002-10-18 |
Mitsui Chemicals Inc |
ヌクレオシドの工業的な製造法
|
US20040204481A1
(en)
|
2001-04-12 |
2004-10-14 |
Pnina Fishman |
Activation of natural killer cells by adenosine A3 receptor agonists
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
US20030124513A1
(en)
|
2001-05-29 |
2003-07-03 |
Mcswiggen James |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of HIV
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
JP2003012690A
(ja)
|
2001-07-03 |
2003-01-15 |
Mitsui Chemicals Inc |
置換イミダゾール誘導体又は置換ベンズイミダゾール誘導体を用いたヌクレオチドの製造法
|
JP2003055392A
(ja)
|
2001-08-08 |
2003-02-26 |
Mitsui Chemicals Inc |
1−リン酸化糖の製造法並びにヌクレオシドの製造法
|
WO2003015798A1
(en)
*
|
2001-08-14 |
2003-02-27 |
Toyama Chemical Co., Ltd. |
Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
JP2005536440A
(ja)
|
2001-09-28 |
2005-12-02 |
イデニクス(ケイマン)リミテツド |
4’位が修飾されたヌクレオシドを使用するフラビウイルスおよびペスチウイルスの治療のための方法および組成物
|
EP1435974A4
(en)
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
METHOD AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS WITH 4'-MODIFIED NUCLEOSIDES
|
US7037718B2
(en)
|
2001-10-26 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
US7125982B1
(en)
|
2001-12-05 |
2006-10-24 |
Frayne Consultants |
Microbial production of nuclease resistant DNA, RNA, and oligo mixtures
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
EP1572705A2
(en)
*
|
2002-01-17 |
2005-09-14 |
Ribapharm, Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
EP1485395A4
(en)
*
|
2002-02-28 |
2011-04-13 |
Biota Scient Management |
NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF
|
US20040023901A1
(en)
|
2002-02-28 |
2004-02-05 |
Cook Phillip D. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
JP2003310293A
(ja)
|
2002-04-26 |
2003-11-05 |
Mitsui Chemicals Inc |
ヌクレオシド化合物の製造法
|
US7569575B2
(en)
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
DE60315444T2
(de)
|
2002-05-08 |
2008-04-30 |
Santaris Pharma A/S |
Synthese von locked nucleic acid-derivaten
|
WO2003099840A1
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
WO2003104250A1
(en)
|
2002-06-07 |
2003-12-18 |
Kylix, B. V. |
New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
|
JP2005533824A
(ja)
|
2002-06-28 |
2005-11-10 |
イデニクス(ケイマン)リミテツド |
フラビウイルス科感染の治療のための2’−c−メチル−3’−o−l−バリンエステルリボフラノシルシチジン
|
MXPA04012709A
(es)
|
2002-06-28 |
2005-09-30 |
Idenix Cayman Ltd |
Profarmacos modificados de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
|
KR20050055630A
(ko)
|
2002-06-28 |
2005-06-13 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
US7094768B2
(en)
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
WO2004052899A2
(en)
|
2002-12-12 |
2004-06-24 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
US7002006B2
(en)
|
2003-02-12 |
2006-02-21 |
Isis Pharmaceuticals, Inc. |
Protection of nucleosides
|
BRPI0407374A
(pt)
|
2003-02-19 |
2006-01-10 |
Univ Yale |
Análogos de nucleosìdeo antiviral e métodos para tratar infecções virais, especialmente infecções de hiv
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
DE602004029904D1
(de)
|
2003-08-27 |
2010-12-16 |
Biota Scient Management |
Neue tricyclische nukleoside oder nukleotide als therapeutische mittel
|
PE20050469A1
(es)
|
2003-09-18 |
2005-09-10 |
Lilly Co Eli |
Modulacion de la expresion de eif4e
|
WO2005034878A2
(en)
|
2003-10-08 |
2005-04-21 |
President And Fellows Of Harvard College |
Pyrovalerone analogs and therapeutic uses thereof
|
DE10348044A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
US7151089B2
(en)
|
2003-10-27 |
2006-12-19 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
EP1725572B1
(de)
|
2003-11-05 |
2017-05-31 |
AGCT GmbH |
Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
|
DK1699459T3
(da)
|
2003-12-29 |
2007-10-08 |
Can Fite Biopharma Ltd |
Fremgangsmåde til behandling af multipel sclerose
|
DE102004009704A1
(de)
|
2004-02-27 |
2005-09-15 |
Dmitry Cherkasov |
Makromolekulare Nukleotidverbindungen und Methoden zu deren Anwendung
|
GB0413726D0
(en)
|
2004-06-18 |
2004-07-21 |
Lauras As |
Compounds
|
WO2006000922A2
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
US7825102B2
(en)
|
2004-07-28 |
2010-11-02 |
Can-Fite Biopharma Ltd. |
Treatment of dry eye conditions
|
DK1778239T3
(da)
|
2004-07-28 |
2013-12-02 |
Can Fite Biopharma Ltd |
Adenosin-a3-receptor-agonister til behandling af sygdomme forbundet medtørre øjne, herunder sjögrens syndrom
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
WO2006050501A2
(en)
|
2004-11-03 |
2006-05-11 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
WO2006097320A2
(de)
|
2005-03-17 |
2006-09-21 |
Genovoxx Gmbh |
Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
|
EP1811982A1
(en)
|
2004-11-08 |
2007-08-01 |
Can-Fite Biopharma Ltd. |
Therapeutic treatment of accelerated bone resorption
|
JP2006131596A
(ja)
|
2004-11-09 |
2006-05-25 |
Univ Nagoya |
ヌクレオチド及びその誘導体の製造方法
|
JP2008523082A
(ja)
*
|
2004-12-09 |
2008-07-03 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
抗菌活性および抗癌活性を有するヌクレオチド
|
EP1828217A2
(en)
|
2004-12-16 |
2007-09-05 |
Febit Biotech GmbH |
Polymerase-independent analysis of the sequence of polynucleotides
|
PT1848718E
(pt)
|
2005-02-04 |
2012-10-11 |
Millennium Pharm Inc |
Inibidores de enzimas de activação e1
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
JP2006248949A
(ja)
|
2005-03-09 |
2006-09-21 |
Univ Nagoya |
ヌクレオシド誘導体、ヌクレオチド誘導体及びそれらの製造方法
|
CA2600359A1
(en)
|
2005-03-09 |
2006-09-09 |
Idenix (Cayman) Limited |
Nucleosides with non-natural bases as anti-viral agents
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
WO2006105440A2
(en)
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
EP1876894A1
(en)
|
2005-04-26 |
2008-01-16 |
The Board of Trustees of the University of Illinois |
Nucleoside compounds and methods of use thereof
|
WO2007006544A2
(en)
|
2005-07-12 |
2007-01-18 |
Vrije Universiteit Brussel |
Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
EP1928475B1
(en)
|
2005-08-15 |
2018-05-23 |
Riboscience LLC |
Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides
|
ES2436404T3
(es)
|
2005-10-03 |
2013-12-30 |
University Health Network |
Inhibidores ODCasa para el tratamiento de malaria
|
KR101388688B1
(ko)
|
2005-11-09 |
2014-04-24 |
토소가부시키가이샤 |
퍼플루오로알킬기를 가진 핵산 염기 및 그 제조방법
|
US20090118220A1
(en)
|
2006-04-03 |
2009-05-07 |
Astrazeneca Ab |
Substituted adenines and the uses thereof
|
WO2007149554A2
(en)
|
2006-06-22 |
2007-12-27 |
The Johns Hopkins University |
Methods for restoring neural function
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
CN101516850B
(zh)
|
2006-08-08 |
2014-05-07 |
米伦纽姆医药公司 |
适用作e1活化酶抑制剂的杂芳基化合物
|
DE102006037786A1
(de)
|
2006-08-11 |
2008-03-20 |
Resprotect Gmbh |
Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung
|
GB0618235D0
(en)
|
2006-09-15 |
2006-10-25 |
Lauras As |
Process
|
WO2008083465A1
(en)
|
2007-01-08 |
2008-07-17 |
University Health Network |
Pyrimidine derivatives as anticancer agents
|
WO2008086042A2
(en)
|
2007-01-10 |
2008-07-17 |
Chisari Francis V |
Preventing infection by a measles or respiratory syncytial virus
|
SG177974A1
(en)
|
2007-01-12 |
2012-02-28 |
Biocryst Pharm Inc |
Antiviral nucleoside analogs
|
US20120135091A1
(en)
|
2007-01-18 |
2012-05-31 |
Roth Mark B |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
KR101483805B1
(ko)
|
2007-01-30 |
2015-01-16 |
파마시클릭스, 인코포레이티드 |
히스톤 데아세틸라제 억제제에 대한 암 내성을 확인하는 방법
|
AU2008210411A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5A derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
|
WO2008100447A2
(en)
|
2007-02-09 |
2008-08-21 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
WO2008117046A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo [4, 3-d] pyrimidines as antibacterial compounds
|
US7964580B2
(en)
*
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US20080255038A1
(en)
|
2007-04-11 |
2008-10-16 |
Samuel Earl Hopkins |
Pharmaceutical compositions
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
PL2014771T3
(pl)
|
2007-06-25 |
2015-05-29 |
Anadys Pharmaceuticals Inc |
Ciągły proces hydrolizy enzymatycznej
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
CN100532388C
(zh)
*
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
EP2019100A1
(en)
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
US20090076062A1
(en)
|
2007-09-13 |
2009-03-19 |
Juergen Klaus Maibaum |
Organic Compounds
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
EP2227234B1
(en)
|
2007-10-15 |
2014-05-07 |
Can-Fite Biopharma Ltd. |
Method for inducing hepatocyte proliferation and uses thereof
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
WO2009086201A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
|
BRPI0908849A2
(pt)
|
2008-02-22 |
2015-08-25 |
Irm Llc |
Composto e composições como c-kit e inibidores de pdgfr quinase
|
US8445669B2
(en)
|
2008-04-10 |
2013-05-21 |
Hamari Chemicals, Ltd. |
Production process of ethynylthymidine compounds from 5-methyluridine as a starting material
|
WO2009126293A2
(en)
|
2008-04-11 |
2009-10-15 |
Yale University |
Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
US20090274686A1
(en)
|
2008-05-02 |
2009-11-05 |
Yat Sun Or |
Nucleoside phosphonate derivatives
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
DE102008035299A1
(de)
|
2008-07-29 |
2010-02-04 |
Resprotect Gmbh |
Konjugat aus Hsp27 und einem Nukleosid, Verfahren zur Phosphorylierung von Hsp27 und Verwendung zur Herstellung eines Arzneimittels
|
GB0815315D0
(en)
|
2008-08-21 |
2008-09-24 |
Univ Leiden |
Organ protection
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
CN102216316A
(zh)
|
2008-09-05 |
2011-10-12 |
寿制药株式会社 |
取代胺衍生物及以其为有效成分的药物组合物
|
WO2010030858A1
(en)
*
|
2008-09-15 |
2010-03-18 |
Enanta Pharmaceuticals, Inc. |
4'-allene-substituted nucleoside derivatives
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
US8883752B2
(en)
|
2008-10-24 |
2014-11-11 |
Isis Pharmaceuticals, Inc. |
5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom
|
US8716263B2
(en)
|
2008-12-23 |
2014-05-06 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
KR101774429B1
(ko)
|
2009-02-06 |
2017-09-04 |
코크리스탈 파마, 아이엔씨. |
암 및 바이러스 감염 치료용 퓨린 뉴클레오시드 모노포스페이트 프로드럭
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
WO2010101951A1
(en)
*
|
2009-03-02 |
2010-09-10 |
Alnylam Pharmaceuticals, Inc. |
Nucleic acid chemical modifications
|
WO2010108140A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Substituted nucleoside and nucleotide analogs
|
WO2010108135A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
MX2011012068A
(es)
|
2009-05-12 |
2012-06-08 |
Southern Res Inst |
Nucleosidos 2'-fluoro arabino y su utilizaicon.
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
US20100331397A1
(en)
|
2009-06-24 |
2010-12-30 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
TW201111378A
(en)
|
2009-09-11 |
2011-04-01 |
Bayer Schering Pharma Ag |
Substituted (heteroarylmethyl) thiohydantoins
|
WO2011057204A2
(en)
|
2009-11-06 |
2011-05-12 |
The Johns Hopkins University |
Lrrk2-mediated neuronal toxicity
|
WO2011100131A2
(en)
|
2010-01-28 |
2011-08-18 |
Alnylam Pharmacuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
US20130109645A1
(en)
|
2010-03-31 |
2013-05-02 |
The united States of America,as represented by Secretary,Dept.,of Health and Human Services |
Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
KR101701510B1
(ko)
|
2010-07-09 |
2017-02-01 |
엘지이노텍 주식회사 |
발광소자
|
EP2596004B1
(en)
|
2010-07-19 |
2014-09-10 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
BR112013001553B1
(pt)
|
2010-07-22 |
2021-01-12 |
Gilead Sciences, Inc. |
compostos antivirais para o tratamento de infecções por paramyxoviridae e composições farmacêuticas que os compreendem
|
JP5640552B2
(ja)
|
2010-08-23 |
2014-12-17 |
セイコーエプソン株式会社 |
制御装置、表示装置及び表示装置の制御方法
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
WO2012040124A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
CN105061534A
(zh)
|
2010-09-22 |
2015-11-18 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
WO2012041965A1
(en)
|
2010-09-29 |
2012-04-05 |
Universidad Nacional De Quilmes |
Process for producing dialkylphosphotriesters of nucleosides by enzymatic transesterification and deprotection thereof for producing nucleoside monophosphates
|
JP5931905B2
(ja)
|
2010-12-03 |
2016-06-08 |
エピザイム,インコーポレイティド |
置換プリン及び7‐デアザプリン化合物
|
EP2655392B1
(en)
|
2010-12-22 |
2018-04-18 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
CN103403014B
(zh)
|
2011-01-03 |
2016-07-06 |
河南美泰宝生物制药有限公司 |
O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
|
CA2843885C
(en)
|
2011-08-01 |
2020-03-10 |
Mbc Pharma, Inc. |
Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
LT2794627T
(lt)
|
2011-12-22 |
2019-01-10 |
Alios Biopharma, Inc. |
Pakeistieji nukleozidai, nukleotidai ir jų analogai
|
US9453014B2
(en)
|
2011-12-22 |
2016-09-27 |
Connexios Life Sciences Pvt. Ltd. |
Cyclic amide derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase and uses thereof
|
WO2013111150A1
(en)
|
2011-12-22 |
2013-08-01 |
Connexios Life Sciences Pvt. Ltd. |
Derivatives of aza adamantane and uses thereof
|
AU2012358804B2
(en)
|
2011-12-22 |
2018-04-19 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
AR089284A1
(es)
|
2011-12-22 |
2014-08-13 |
Galapagos Nv |
Dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de trastornos inflamatorios
|
PE20141598A1
(es)
|
2011-12-22 |
2014-11-14 |
Novartis Ag |
Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
|
EP3351552B1
(en)
|
2012-03-13 |
2021-05-19 |
Gilead Sciences, Inc. |
2'-substituted carba-nucleoside analogs for antiviral treatment
|
WO2013138210A1
(en)
|
2012-03-14 |
2013-09-19 |
Ning Xi |
Substituted cyclic compounds and methods of use
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
PL2827875T3
(pl)
|
2012-03-21 |
2019-07-31 |
Janssen Biopharma, Inc. |
Podstawione nukleozydy, nukleotydy i ich analogi
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013142125A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleotide analogs
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
EP2852603B1
(en)
|
2012-05-22 |
2021-05-12 |
Idenix Pharmaceuticals LLC |
D-amino acid compounds for liver disease
|
KR20150027155A
(ko)
|
2012-07-03 |
2015-03-11 |
브리스톨-마이어스 스큅 컴퍼니 |
바이러스 감염의 치료를 위한 뉴클레오시드 화합물의 부분입체이성질체적으로 풍부한 포스포르아미데이트 유도체의 제조 방법
|
WO2014022639A1
(en)
|
2012-08-01 |
2014-02-06 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3',4'-dihydro-2'h-spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]-1-yl)methanone
|
WO2014026198A1
(en)
|
2012-08-10 |
2014-02-13 |
Epizyme, Inc. |
Inhibitors of protein methyltransferase dot1l and methods of use thereof
|
US10294261B2
(en)
|
2012-09-04 |
2019-05-21 |
Kabushiki Kaisha Dnaform |
Compound, nucleic acid, labeling substance, and detection method
|
CN104640858B
(zh)
|
2012-09-26 |
2018-11-06 |
霍夫曼-拉罗奇有限公司 |
环醚吡唑-4-基-杂环基-甲酰胺化合物及使用方法
|
BR112015006524A8
(pt)
|
2012-09-26 |
2019-08-20 |
Merck Patent Gmbh |
derivados de quinazolinona como inibidores de parp, seu processo de preparação, seu uso, medicamentos e conjunto (kit)
|
CA2889717A1
(en)
|
2012-10-29 |
2014-05-08 |
Cocrystal Pharma, Inc. |
Pyrimidine nucleotides and their monophosphate prodrugs for treatment of viral infections and cancer
|
GB201220843D0
(en)
|
2012-11-20 |
2013-01-02 |
Univ College Cork Nat Univ Ie |
Compound
|
CA2894541A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
KR102168621B1
(ko)
|
2012-12-21 |
2020-10-22 |
얀센 바이오파마, 인코퍼레이트. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
CA2908313A1
(en)
|
2013-04-05 |
2014-10-09 |
Alios Biopharma, Inc. |
Hepatitis c viral infection treatment using a combination of compounds
|
ES2825035T3
(es)
|
2013-06-26 |
2021-05-14 |
Janssen Biopharma Inc |
Nucleósidos, nucleótidos y análogos de estos sustituidos con 4-azidoalquilo
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
AU2014331863C1
(en)
|
2013-10-11 |
2019-05-16 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CA2952959C
(en)
|
2014-06-24 |
2023-03-07 |
Alios Biopharma, Inc. |
Use of nucleosides and nucleotides to treat filoviridae viral infection
|
JP2017519779A
(ja)
|
2014-06-24 |
2017-07-20 |
アリオス バイオファーマ インク. |
置換されたヌクレオチド類似体を調製する方法
|
EP3797782A1
(en)
|
2014-06-24 |
2021-03-31 |
Janssen BioPharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof for use in the treatment of viral infections
|
US20160022724A1
(en)
|
2014-07-22 |
2016-01-28 |
Alios Biopharma, Inc. |
Methods for treating paramyxoviruses
|
CN106999509A
(zh)
|
2014-08-05 |
2017-08-01 |
艾丽奥斯生物制药有限公司 |
用于治疗副粘病毒的联合治疗
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2’-氯胺基嘧啶酮及嘧啶二酮核苷類
|
US9981175B2
(en)
|
2014-09-12 |
2018-05-29 |
Dan DeLaRosa |
Taekwondo bag
|
CN107108681B
(zh)
|
2014-10-28 |
2021-04-06 |
詹森生物制药有限公司 |
制备取代的核苷类似物的方法
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
TW201811339A
(zh)
|
2016-08-12 |
2018-04-01 |
美商艾洛斯生物製藥公司 |
經取代之核苷、核苷酸及其類似物
|
WO2018081449A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|